Detalles de la búsqueda
1.
Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer.
Pharmacogenomics J
; 19(1): 15-24, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29472587
2.
PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer.
Br J Cancer
; 111(9): 1757-64, 2014 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25233397
3.
Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors.
Clin Transl Oncol
; 20(2): 140-149, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28631135
4.
Long-term clinical benefit from salvage EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer patients with EGFR wild-type tumors
Clin. transl. oncol. (Print)
; 20(2): 140-149, feb. 2018. tab, graf
Artículo
en Inglés
| IBECS (España) | ID: ibc-170553
Resultados
1 -
4
de 4
1
Próxima >
>>